Related Articles
Sun Pharmaceutical Appoints Kirti Ganorkar as Managing Director, Signaling Leadership Evolution
Sun Pharmaceutical Industries Ltd $SUNPHARMA.NS, the largest drugmaker in India by revenue, announced a significant leadership change on Friday. Kirti Ganorkar has been appointed as managing director, effective September 1, marking a strategic evolution in the company’s executive management. Meanwhile, Dilip Shanghvi, the founding leader who has been instrumental in shaping Sun Pharma’s growth, will continue to serve as executive director and chair the board, ensuring continuity in governance.
IFC Commits $700 Million to Pakistan’s Reko Diq Copper-Gold Mine
The International Finance Corporation (IFC), a member of the World Bank Group, has stepped up its financial support for Pakistan’s Reko Diq copper-gold mining project with an additional subordinated loan of $400 million. This commitment follows an earlier $300 million funding tranche announced in April, bringing IFC’s total financing to $700 million. The ambitious $6.6 billion project underscores the importance of international capital flows into resource infrastructure in emerging markets.
Thermo Fisher Eyes $4 Billion Divestiture of Diagnostics Unit to Streamline Portfolio
Thermo Fisher Scientific Inc. $TMO, one of the world’s largest life sciences and biotechnology companies, is reportedly seeking to sell its diagnostics business for approximately $4 billion USD, according to the Financial Times. The move signals a broader strategy to divest lower-margin and slower-growing segments in favor of focusing on core areas such as contract drug manufacturing and advanced analytical technologies.
This deal might settle the suit, but it doesn't necessarily settle the issue of corporate fairness.
While this settlement silences the lawsuit, it raises deeper concerns about lasting corporate bias.